3D Bioprinting Market Is Predicted To Grow Swiftly Due To Rising Prevalence Of Chronic Diseases Till 2022: Grand View Research, Inc.
Global 3D bioprinting market is expected to reach USD
1.82 billion by 2022, according to a new report by Grand View Research Inc.
Rising prevalence of chronic diseases such as Chronic Kidney Disease (CKD)
which demands kidney transplantation is expected to boost the market growth, as
3D bioprinting is convenient and cost effective substitute for organ
transplantation.
Emerging
medical applications of 3D bioprinting such as toxicity testing, drug
discovery, tissue engineering and consumer product testing are expected to
further drive the market growth positively. Increasing R&D expenditure is
anticipated to be high impact rendering driver for the industry. 3D bioprinting
advances in tissue engineering and allows developments to be done using biomaterials
which have better biocompatibility. Moreover, rising geriatric population is
expected to assist the market growth, as this demographic is highly susceptible
to age related organ deformities.
North
America 3D bioprinting market share, by technology, 2012-2022 (USD Million)
Browse full
research report on 3D Bioprinting Market: https://www.grandviewresearch.com/industry-analysis/3d-bioprinting-market
Further key findings from the report suggest:
- Syringe based printers dominated the technology
segment as these printers allow working in sterile environment. Moreover,
syringe based printers have wide applications which include fabrication of
scaffolds, cell strips printing, and tissue printing.
- Magnetic levitation based printers are expected
to witness lucrative growth over the forecast period. This can be
attributed to emerging medical applications such as screening of
cardiovascular toxicity, human cell modeling and smooth muscle printing.
- The medical applications segment is expected to
gain substantial share of over 32.0% by 2022 which can be attributed to
emerging applications of 3D bioprinting such as toxicity screening, organ
transplants and medical pills.
- Dental application segment is expected to
witness lucrative growth over the forecast period. Rising demand for
cosmetic dentistry along with growing awareness about oral hygiene are
expected to foster the demand for dental applications.
- North America dominated the regional 3D
bioprinting market with over 35.0% share and is expected to grow at a CAGR
of 10.0%. Supportive government initiatives to improve healthcare
infrastructure coupled with growing disposable income are vital driving
factor for this region’s growth.
- Asia Pacific is expected to witness lucrative
growth over the forecast period. Favorable government support to improve
healthcare delivery with economic developments in emerging countries such
as India and China are expected to increase the demand for 3D bioprinting.
- Key players operating in the 3D bioprinting
industry include Organovo Holding Inc., Cyfuse Biomedical, BioBots,
Luxexcel Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics
Systems, Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC,
Bio3D Technologies, Solidscape and others.
- These players are involved in various strategic
initiatives such as new product launches, strategic alliances and mergers
and acquisitions to gain the edge over the competitors. For instance, In
June 2015, Orgonovo collaborated with L’Oreal to develop skin tissue using
NovoGen Bioprinting platform.
Browse more
reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global 3D bioprinting market on the
basis of products and region:
3D
Bioprinting Market Technology Outlook (USD million), 2012 - 2022
- Magnetic
levitation
- Inkjet
based
- Syringe
based
- Laser
based
- Other
3D
Bioprinting Market Application Outlook (USD million), 2012 - 2022
- Medical
- Tissue
and organ generation
- Medical
pills
- Prosthetics
and implants
- Dental
- Biosensors
- Consumer/Personal
products testing
- Bioinks
- Food and
animal product bioprinting
3D
Bioprinting Market Regional Outlook (USD million), 2012 - 2022
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- MEA
- South
Africa.
Access
Press Release By Grand View Research: https://www.grandviewresearch.com/press-release/global-3d-bioprinting-market
About Grand View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
https://laserlasikeyesurgeryreviewsyodamia.blogspot.com/2017/03/best-lasik-eye-surgery-indianapolis.html?showComment=1533624661733#c8524738516406734388
ReplyDeleteThank you for sharing this information with me. We encourage you to click on the title if you are concerned about the speed of the space bar. With this tool, you can easily challenge the Spacebar Clicker by improving the space bar.
ReplyDelete